H pylori eradication

DRUG3 trials

Sponsors

Kyungpook National University Hospital, National Taiwan University Hospital, Assiut University

Conditions

Gastric CancerGastroesophageal Reflux DiseaseHelicobacter Pylori Infection, Susceptibility to

Phase 4

Symptom Assessment for Patients With Gastro-esophageal Reflux Disease Receiving Helicobacter Pylori Eradication

National Taiwan University HospitalGastroesophageal Reflux Disease

Start: 2016-10-31End: 2019-09-30Target: 400Updated: 2016-10-19

Unknown Phase

The Efficacy of Serum Pepsinogen for Prediction of Metachronous Gastric Neoplasm

CompletedNCT02682446

Kyungpook National University HospitalGastric Cancer

Start: 2007-01-31End: 2015-12-31Updated: 2016-02-15

Helicobacter Pylori Infection Among Women With Recurrent Abortion of Unknown Cause

Not yet recruitingNCT07293169

Assiut UniversityHelicobacter Pylori Infection, Susceptibility to

Start: 2025-12-31End: 2026-12-31Target: 100Updated: 2025-12-19

Related Papers

Rebound of Reflux‐Related Symptoms After <i>Helicobacter pylori</i> Eradication in Patients With Gastroesophageal Reflux Disease: A Prospective Randomized Study

Helicobacter2025-01-013 citations

<i>Helicobacter pylori</i> infection and serum level of pepsinogen are associated with the risk of metachronous gastric neoplasm after endoscopic resection

Alimentary Pharmacology & Therapeutics2017-08-1122 citations